Article info
PDFDiagnosis
Cost effectiveness analysis
Hammering the point home: serologic testing costs more and harms more patients than other strategies for the diagnosis of active tuberculosis in India
- Correspondence to Dick Menzies
Department of Respiratory and Epidemiology, Montreal Chest, 3650 St. Urbain, Montreal, QC H2X2P4, Canada; dick.menzies{at}mcgill.ca
Citation
Hammering the point home: serologic testing costs more and harms more patients than other strategies for the diagnosis of active tuberculosis in India
Publication history
- First published December 7, 2011.
Online issue publication
October 25, 2017
Article Versions
- Previous version (25 October 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions